Abstract A novel compound, N 6-(4-hydroxybenzyl) adenosine, isolated from Gastrodia elata and which has been shown to be a potential therapeutic agent for preventing and treating neurodegenerative disease, was found to target both the adenosine A 2A receptor (A 2A R) and the equilibrative nucleoside transporter 1 (ENT1). As A 2A R and ENT1 are proximal in the synaptic crevice of striatum, where the mutant huntingtin aggregate is located, the dual ...